Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis

European Journal of Heart Failure

Volumn 9, Issue 2, 2007, Pages 152-159

  Suzuki, Jun ichi ^a   Ogawa, Masahito ^a   Futamatsu, Hideki ^a   Kosuge, Hisanori ^a   Sagesaka, Yuko M ^a   Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Echocardiogram; Inflammation; Myocardial remodelling; Myocarditis; Nuclear factor

Indexed keywords

CARDIAC MYOSIN; CATECHIN; CYTOKINE; EPICATHECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; SODIUM CHLORIDE; THEA FLAN 90S; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEWIS RAT; LYMPHOCYTE PROLIFERATION; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; TEA; TH2 CELL;

ANIMALS; CATECHIN; CYTOKINES; FIBROSIS; HEART VENTRICLES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MODELS, ANIMAL; MYOCARDIUM; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; RATS; TEA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947121208     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2006.05.007     Document Type: Article

References (40)

1. Haas G.J. Etiology, evaluation, and management of acute myocarditis. Cardiol Rev 9 (2001) 88-95
2. Oakley C.M. Myocarditis, pericarditis and other pericardial diseases. Heart 84 (2000) 449-454
3. Batra A.S., and Lewis A.B. Acute myocarditis. Curr Opin Pediatr 13 (2001) 234-239
4. Zee-Cheng C.S., Tsai C.C., Palmer D.C., et al. High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy. J Am Coll Cardiol 3 (1984) 63-70
5. Parrillo J.E., Aretz H.T., Palacios I., Fallon J.T., and Block P. The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure: endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis. Circulation 69 (1984) 93-101
6. Frustaci A., Chimenti C., Calabrese F., Pieroni M., Thiene G., and Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107 (2003) 857-863
7. Liu P.P., and Mason J.W. Advances in the understanding of myocarditis. Circulation 104 (2001) 1076-1082
8. Kuhl U., Pauschinger M., Schwimmbeck P.L., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 (2003) 2793-2798
9. Matsumoto Y., Jee Y., and Sugisaki M. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR. J Immunol 164 (2000) 2248-2254
10. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy : two-year follow-up results. Circulation 104 (2001) 39-45
11. Ishikawa T., Suzukawa M., Ito T., et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 66 (1997) 261-266
12. Junkun J., Selman S.H., Swiercz R., and Skrzypczak-Jankun E. Why drinking tea could prevent cancer. Nature 387 (1997) 561
13. Beecher G.R., Warden B.A., and Merken H. Analysis of tea polyphenols. Proc Soc Exp Biol Med 220 (1999) 267-270
14. Yang C.S., Landau J.M., Huang M.T., and Newmark H.L. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21 (2001) 381-406
15. Lin Y.L., and Lin J.K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol 52 (1997) 465-472
16. Benelli R., Vene R., Bisacchi D., Garbisa S., and Albini A. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Biol Chem 383 (2002) 101-105
17. Liu P., Martino T., Opavsky M.A., and Penninger J. Viral myocarditis: balance between viral infection and immune response. Can J Cardiol 12 (1996) 935-943
18. Kuhl U., Pauschinger M., Bock T., et al. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108 (2003) 945-950
19. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57 (1990) 250-262
20. Kodama M., and Izumi T. Experimental autoimmune myocarditis. Acta Med Biol 39 (1991) 1-10
21. Kitabayashi H., Isobe M., Watanabe N., Suzuki J., Yazaki Y., and Sekiguchi M. FTY 720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J Cardiovasc Pharmacol 35 (2000) 410-416
22. Yokoseki O., Suzuki J., Kitabayashi H., et al. cis element decoy against nuclear factor-κB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 89 (2001) 899-906
23. Futamatsu H., Suzuki J., Kosuge H., et al. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc Res 59 (2003) 95-104
24. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
25. Litwin S.E., Katz S.E., Morgan J.P., and Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89 (1994) 345-354
26. Seko Y., Takahashi N., Azuma M., Yagita H., Okumura K., and Yazaki Y. Effects of in vivo administration of anti-B7-1/B7-2 monoclonal anti-bodies on murine acute myocarditis caused by coxsackie virus B3. Circ Res 82 (1998) 613-618
27. Suzuki J., Cole S.E., Batirel S., et al. Tumor necrosis factor receptor-1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts. Am J Transplant 3 (2003) 968-976
28. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 130 (2000) 2073S-2085S (8S Suppl)
29. Weisburger J.H. Lifestyle, health and disease prevention: the underlying mechanisms. Eur J Cancer Prev 11 (2002) 1-7 (Suppl 2: S)
30. Aviram M., Dornfeld L., Kaplan M., et al. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res 28 (2002) 49-62
31. Lambert J.D., and Yang C.S. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 523-524 (2003) 201-208
32. Takabayashi F., and Harada N. Effects of green tea catechins (Polyphenon 100) on cerulein-induced acute pancreatitis in rats. Pancreas 14 (1997) 276-279
33. Locher R., Emmanuele L., Suter P.M., Vetter W., and Barton M. Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol 434 (2002) 1-7
34. Lin J.K., Liang Y.C., and Lin-Shiau S.Y. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol 58 (1999) 911-915
35. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest 68 (1993) 499-508
36. Dona M., Dell'Aica I., Calabrese F., et al. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J Immunol 170 (2003) 4335-4341
37. Lotze U., Heinke S., Fritzenwanger M., Krack A., Muller S., and Figulla H.R. Carvedilol inhibits platelet-derived growth factor-induced signal transduction in human cardiac fibroblasts. J Cardiovasc Pharmacol 39 (2002) 576-589
38. Suzuki J., Ogawa M., Sagesaka Y.M., and Isobe M. Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts. Cardiovasc Res 69 (2006) 272-279
39. Song J.M., Lee K.H., and Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res 68 (2005) 66-74
40. Weber J.M., Ruzindana-Umunyana A., Imbeault L., and Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res 58 (2003) 167-173